Pfizer Ventures
Overview
Pfizer Ventures, the venture capital arm of Pfizer Inc., was founded in 2004 and invests for return in areas of current or future strategic interest to Pfizer . Pfizer Ventures seeks to remain at the forefront of life science advances, looking to identify and invest in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer's pipeline and shape the future of the biopharmaceutical industry . The firm invests in areas of current or future strategic interest to Pfizer with the goal of remaining at the forefront of life science advances . They identify and invest in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer's pipeline and shape the future of the industry .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TRexBio | Jan 2026 | Series B Extension | Co-investor |
| Vibrant Therapeutics | Jan 2026 | Early Funding | Lead |
| Enodia Therapeutics | Jan 2026 | Seed | Lead |
| FoRx Therapeutics | Dec 2025 | Series A | Co-investor |
| TRIANA Biomedicines | Dec 2025 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.